There’s nothing more important than our health, and keeping up on the latest information regarding everything from the common cold to pandemics, and the latest in the treatment of illnesses and diseases that effect all of us is tantamount. Syndicated World News keeps you up to date with unbiased reliable information.
- High density of street trees may help improve mental healthon Jan 26, 2021 at 4:32 am
Depression, especially in urban areas, is on the rise, now more than ever. Mental health outcomes are influenced by, among other things, the type of environment where one lives.
- Circulating antiphospholipid antibodies drive endothelial cell activation in COVID-19on Jan 26, 2021 at 4:14 am
With the emergence of COVID-19 (coronavirus disease 2019), researchers have been closely investigating the complex interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the human immune system, and COVID-19 disease severity.
- First-of-its-kind cardiovascular drug gets FDA approval based on study from Canadian VIGOUR Centreon Jan 26, 2021 at 4:07 am
The U.S. Food and Drug Administration has approved the drug vericiguat for use in patients with heart failure.
- DARPA funding brings wireless communication between brains one step closer to realityon Jan 26, 2021 at 4:01 am
Wireless communication directly between brains is one step closer to reality thanks to $8 million in Department of Defense follow-up funding for Rice University neuroengineers.
- American Heart Association committed to support more than $230 million to achieve health equityon Jan 26, 2021 at 3:58 am
The American Heart Association, the leading global voluntary health organization dedicated to fighting heart disease and stroke, is making an unprecedented series of investments focused on enhancing its historic commitment to addressing the social determinants of health and the barriers to achieving health equity for all communities – urban, suburban and rural.
- Probiotics as adjuvant therapy for COVID-19 patientson Jan 26, 2021 at 3:57 am
In a recent review published in the Journal of Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Luigi Santacroce and Francesco Inchingolo et al. address the many factors such as dysbiosis (imbalance in the microbiota) that could influence the SARS-CoV-2 infection course.
- Reducing loneliness may decrease suicidality risk among adolescents having depressed motherson Jan 26, 2021 at 3:49 am
Children of mothers experiencing depressive symptoms are more at risk, as adolescents, of experiencing suicidal thoughts and attempting suicide.
- New SARS-CoV-2 variants resistant to convalescent sera and and monoclonal antibodieson Jan 26, 2021 at 3:39 am
Researchers studying the effect of convalescent sera and monoclonal antibodies from recovered patients found the UK and South African SARS-CoV-2 variants are more resistant to neutralization compared to the wild-type virus.
- Study shows link between early brainstem tau accumulation and cortical hyperexcitabilityon Jan 26, 2021 at 3:32 am
Study conducted by researchers from the GIGA CRC In vivo Imaging laboratory at ULiège demonstrates, for the first time in humans, how the first deposits of tau proteins in the brainstem are associated with neurophysiological processes specific to the early stages of Alzheimer’s disease development.
- World’s first fully reversible manipulation of the circadian clockon Jan 26, 2021 at 3:14 am
The Nagoya University Institute of Transformative Bio-Molecules research team of Designated Associate Professor Tsuyoshi Hirota, Postdoctoral Fellow Simon Miller, Professor Kenichiro Itami and graduate student Tsuyoshi Oshima (Research Fellowship for Young Scientists, JSPS), in collaboration with the group of Professor Ben Feringa and Postdoctoral Fellow Dušan Kolarski of Groningen University in the Netherlands, have achieved a world first: fully reversible manipulation of the period of the circadian clock using light, by exchanging part of a compound with a light-activated switch.
- STAT+: European Ombudsman probes failure to disclose Covid-19 vaccine contractsby Ed Silverman on Jan 25, 2021 at 5:11 pm
“Transparency is crucial for informed public debate, democratic accountability, and public trust,” said Olivier Hoedeman of Corporate Europe Observatory.
- STAT+: Pharmalittle: Merck halts development of Covid-19 vaccines; Moderna starts work on booster shot to combat variantsby Ed Silverman on Jan 25, 2021 at 2:22 pm
Merck will stop developing both formulations of the Covid-19 vaccines the company was working on, citing inadequate immune responses to the shots.
- Moderna’s vaccine is less potent against one coronavirus variant but still protective, company saysby Andrew Joseph on Jan 25, 2021 at 2:16 pm
Moderna is studying whether booster doses could be necessary after finding its Covid-19 vaccine was less effective against a coronavirus variant that was first identified in South Africa.
- In a major setback, Merck to stop developing its two Covid-19 vaccines and focus on therapiesby Matthew Herper and Helen Branswell on Jan 25, 2021 at 11:45 am
As Merck bows out of the race to develop Covid-19 vaccines, it plans to continue developing treatments for the disease.
- Opinion: The number of Americans without health insurance has been trending up. Let’s turn it down againby Sara R. Collins on Jan 25, 2021 at 9:40 am
A new administration and Congress getting to work offers an opportunity to reverse the uninsured trend line. This can be done quickly and without sweeping change to the health system.…
- Covid-19 vaccine basics: Why the rollout is so slow, who can get doses, and what about side effectsby Helen Branswell on Jan 25, 2021 at 9:35 am
Covid-19 vaccine basics: Why the rollout is so slow, when it will pick up, and who can get it.
- Undercounting of Covid-19 deaths is greatest in pro-Trump areas, analysis showsby Olivia Goldhill on Jan 25, 2021 at 9:30 am
The analysis suggests that political leanings have helped suppress the true scale of Covid-19 deaths. In cases where the deceased didn’t have a Covid-19 test, a coroner or medical examiner…
- ‘I’m not looking to be vindicated,’ Deborah Birx says in televised interviewby Kate Sheridan on Jan 24, 2021 at 7:43 pm
Deborah Birx said she waited to give an interview about her experiences as the coordinator of the White House Coronavirus Task Force until after President Joe Biden’s inauguration.
- STAT+: Aurinia secures FDA drug approval for autoimmune kidney disease, with label offering stronger patent protectionby Adam Feuerstein on Jan 24, 2021 at 6:30 pm
Aurinia Pharmaceuticals won approval to market a new medicine for patients with lupus nephritis, a serious autoimmune kidney disease.
- Opinion: The stakes for choosing the right FDA commissioner couldn’t be higherby Daniel Carpenter and Gregg Gonsalves on Jan 24, 2021 at 12:00 pm
As a weary and uncertain America faces the likelihood of needing continual rollout of new coronavirus treatments in the years to come, the stakes for President Biden’s choice for FDA…